• Contagion LiveContagion Live
  • CGTLive logoCGTLive logo
  • HCP LiveHCP Live
  • Neurology Live
  • OncLiveOncLive
NeurologyLive – Clinical Neurology News and Neurology Expert Insights
NeurologyLive – Clinical Neurology News and Neurology Expert Insights
Spotlight
Future Leaders in NeurologyNMOSD Disease SpotlightAHS 2022ATMRD 2022SLEEP 2022
Clinical Focus
View MoreDementia/AlzheimerEpilepsyHeadache/MigraineMovement DisordersMultiple SclerosisNeuromuscularSleep MedicineStroke
Video Series
Cure ConnectionsInsightsNeurologyLive Peer ExchangeNews Network
News
Media
All Videos
Medical World News
Podcasts
Weekly Recap
Cure Connections
Insights
News Network
NeurologyLive Peer Exchange
Conferences
Conference Coverage
Conference Listing
CME/CEPartners
Publications
NeurologyLive
International Journal of MS Care
Resources
Disease Spotlight
Fellows' Corner
Future Leaders in Neurology
Giants of Multiple Sclerosis
Interactive Tools
Live Events
Neurology Resources
Virtual Events
Subscribe
  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy

© 2022 MJH Life Sciences and NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Spotlight
  • Future Leaders in Neurology
  • NMOSD Disease Spotlight
  • AHS 2022
  • ATMRD 2022
  • SLEEP 2022
Clinical FocusSee All >
  • Dementia/Alzheimer
  • Epilepsy
  • Headache/Migraine
  • Movement Disorders
  • Multiple Sclerosis
  • Neuromuscular
  • Sleep Medicine
  • Stroke
Video Series
  • Cure Connections
  • Insights
  • NeurologyLive Peer Exchange
  • News Network
  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Rapid Readout: Expert Perspectives on Multiple Sclerosis - Data from the 8th Joint ACTRIMS-ECTRIMS Meeting 2020

Experts in multiple sclerosis review top data presented at the 8th joint ACTRIMS-ECTRIMS meeting.

EP. 1: Ofatumumab vs Teriflunomide: ASCLEPIOS I/II RMS Trials

November 24th 2020

EP. 2: OLKIOS: Looking at Ofatumumab’s Continued Efficacy

November 24th 2020

EP. 3: OPTIMUM: Ponesimod Superiority in MRI-based Outcomes in RRMS

November 24th 2020

EP. 4: Rationale for Selected Dosing Regimen of Evobrutinib in Phase 3 Studies

November 24th 2020

EP. 5: Takeaways From ACTRIMS-ECTRIMS 2020 Meeting

November 24th 2020

EP. 6: Phase 3 ASCLEPIOS I/II Open-Label Extension Study: Ofatumumab vs Teriflunomide

November 24th 2020

EP. 7: OLKIOS Phase 3b Trial: Pivotal Endpoints and Potential Significance

November 24th 2020

EP. 8: OPTIMUM Phase 3 Trial: Ponesimod’s Cardiac Safety Data

November 24th 2020

EP. 9: Ozanimod Compared to Teriflunomide Utilizing Statistical Matching

November 24th 2020

EP. 10: Key Takeaways from the 8th ACTRIMS-ECTRIMS 2020 Meeting

November 24th 2020

Latest News

ALS-Related Biomarkers Remain Unchanged With PrimeC Combination Treatment

Awareness of Botulinum Toxins in the Movement Disorder Landscape: Laxman Bahroo, DO

Pioneering Care for Autoimmune Disorders Through Research and Results: The Mayo Clinic Way

NeuroVoices: Heidi Schambra, MD, on Expanding Capabilities of Stroke Rehabilitation With the PrimSeq Digital Tool

View More News